Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Viscum album (Iscador P) in breast cancer
NCT00176046Phase 4Completed
- Sponsor
- Heidelberg University
- Start
- May 1999
- Primary completion
- Jun 2009
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of Iscador P in breast cancer (2 arms), sponsored by Heidelberg University. Primary endpoints: blood count, lymphocytes and 5 more. Started May 1999; status: completed.
02
Drugs
Iscador P
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00176046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176046.